Thermo Fisher Scientific

Equities

TMO

US8835561023

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 04:00:01 2024-04-26 pm EDT			5-day change	1st Jan Change
573.6 ^USD	+0.33%		+5.29%	+8.07%

Apr. 26	Redburn Atlantic Adjusts Price Target on Thermo Fisher Scientific to $620 From $615	MT
Apr. 25	Deutsche Bank Adjusts Price Target on Thermo Fisher Scientific to $610 From $600	MT

Thermo Fisher Scientific Inc. announces an Equity Buyback for $3,000 million worth of its shares.

September 23, 2021 at 04:05 pm EDT

Thermo Fisher Scientific Inc. (NYSE:TMO) announces a share repurchase program. Under the program, the company will repurchase up to $3,000 million worth of its common stock. The repurchase program has no expiration date.

Latest news about Thermo Fisher Scientific

Redburn Atlantic Adjusts Price Target on Thermo Fisher Scientific to $620 From $615	Apr. 26	MT
Deutsche Bank Adjusts Price Target on Thermo Fisher Scientific to $610 From $600	Apr. 25	MT
TD Cowen Adjusts Price Target on Thermo Fisher Scientific to $648 From $644	Apr. 25	MT
Bernstein Adjusts Thermo Fisher Scientific Price Target to $553 From $544	Apr. 25	MT
JPMorgan Adjusts Thermo Fisher Scientific Price Target to $650 From $600	Apr. 25	MT
Morgan Stanley Raises Price Target on Thermo Fisher Scientific to $650 From $620, Keeps Overweight Rating	Apr. 25	MT
Stifel Adjusts Price Target on Thermo Fisher Scientific to $600 From $595	Apr. 25	MT
Goldman Sachs Adjusts Price Target on Thermo Fisher Scientific to $650 From $640	Apr. 25	MT
Barclays Adjusts Price Target on Thermo Fisher Scientific to $615 From $590	Apr. 25	MT
RBC Adjusts Price Target on Thermo Fisher Scientific to $662 From $657	Apr. 25	MT
Wolfe Research Raises Thermo Fisher Scientific's Price Target to $625 From $615	Apr. 24	MT
Baird Trims Thermo Fisher Scientific's Price Target to $620 From $621	Apr. 24	MT
Top Midday Stories: Tesla, Boston Scientific Shares Jump Post-Earnings; Major Airline Stocks Down on New DOT Rules; B. Riley Finally Submits 10-K, Sends Stock Soaring	Apr. 24	MT
Global markets live: Heineken, AT&T Hasbro, Visa, Boeing...	Apr. 24
Evercore ISI Adjusts Price Target on Thermo Fisher Scientific to $615 From $610	Apr. 24	MT
Transcript : Thermo Fisher Scientific Inc., Q1 2024 Earnings Call, Apr 24, 2024	Apr. 24
Futures Mostly Rise in Premarket Ahead of More Corporate Earnings; Asia, Europe Up	Apr. 24	MT
Tech Strength Lifts Wall Street Pre-Bell; Asia Rallies, Europe Up	Apr. 24	MT
Thermo Fisher lifts profit forecast as medical equipment demand improves	Apr. 24	RE
Thermo Fisher's Fiscal Q1 Adjusted Earnings Rise While Revenue Falls; Fiscal 2024 Outlook Updated -- Shares Advance Pre-Bell	Apr. 24	MT
Thermo Fisher Scientific 1Q Revenue Tops Estimates, Raises 2024 Outlook	Apr. 24	DJ
Earnings Flash (TMO) THERMO FISHER SCIENTIFIC Reports Q1 Revenue $10.35B, vs. Street Est of $10.18B	Apr. 24	MT
Earnings Flash (TMO) THERMO FISHER SCIENTIFIC Reports Q1 EPS $5.11, vs. Street Est of $4.71	Apr. 24	MT
Tranche Update on Thermo Fisher Scientific Inc.'s Equity Buyback Plan announced on November 14, 2023.	Apr. 24	CI
Thermo Fisher Scientific Inc. Raises Revenue Guidance for the Full Year 2024	Apr. 24	CI

Chart Thermo Fisher Scientific

Duration

Period

More charts

Company Profile

Thermo Fisher Scientific Inc. specializes in the design, manufacturing and marketing of laboratory and scientific equipments. Net sales (including intragroup) break down by family of products as follows: - laboratory equipments (70%). Moreover, the group proposes chemical products (reagents, solvent, salts, etc.), consumable products (tubes, funnels, vials, etc.), as well as conditioning, warehousing, storage, etc.; - diagnostics equipment and products (15.3%); - scientific analysis equipments (14.7%): analyzer (of water, gas, grounds, etc.), mass spectrometers, molecular spectroscopes, microscopes, manometers, samplers, microbiology equipments, reactive agents, etc. Net sales break down by source of income into products sales (78.5%) and services (21.5%). Net sales break down geographically as follows: North America (53%), Europe (25.7%), Asia-Pacific (18.1%) and others (3.2%).

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-22 - Annual General Meeting

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Thermo Fisher Scientific

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

573.6 USD

Average target price

618.2 USD

Spread / Average Target

+7.78%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERMO FISHER SCIENTIFIC	+8.07%	218B
DANAHER CORPORATION	+6.59%	182B
INTUITIVE SURGICAL, INC.	+11.26%	132B
BOSTON SCIENTIFIC CORPORATION	+26.57%	108B
EDWARDS LIFESCIENCES CORPORATION	+13.35%	52.98B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.62%	47.59B
AGILENT TECHNOLOGIES, INC.	-0.93%	39.96B
GE HEALTHCARE TECHNOLOGIES INC.	+11.54%	39.22B
RESMED, INC.	+26.76%	26.94B
ILLUMINA, INC.	-12.18%	19.28B

Other Advanced Medical Equipment & Technology